AGP Picks
View all

World Wellness Times
Provided by AGP

World Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Wellness Times.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on August 5, 2026

Seres Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates, Including Further Action to Reduce Ongoing Facilities Costs
Aug. 5, 2026

Seres Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates, Including Further Action to Reduce Ongoing Facilities Costs

Indeterminate GlobeNewswire
Rapport Therapeutics Reports Second Quarter 2026 Financials and Provides Business Update
Aug. 5, 2026

Rapport Therapeutics Reports Second Quarter 2026 Financials and Provides Business Update

Indeterminate GlobeNewswire
Tonix Pharmaceuticals to Participate in Upcoming Investor Conferences
Aug. 5, 2026

Tonix Pharmaceuticals to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Verano Announces Strong Second Quarter 2026 Financial Results Highlighted by $218 Million in Revenue
Aug. 5, 2026

Verano Announces Strong Second Quarter 2026 Financial Results Highlighted by $218 Million in Revenue

Indeterminate GlobeNewswire
Shopify Delivers Big: 30%+ Growth Across GMV, Revenue, Gross Profit, and Free Cash Flow
Aug. 5, 2026

Shopify Delivers Big: 30%+ Growth Across GMV, Revenue, Gross Profit, and Free Cash Flow

Indeterminate GlobeNewswire
Lexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for LX2020 for the Treatment of PKP2 Arrhythmogenic Cardiomyopathy
Aug. 5, 2026

Lexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for LX2020 for the Treatment of PKP2 Arrhythmogenic Cardiomyopathy

Indeterminate GlobeNewswire
Telix to Host R&D Day in New York City on September 22, 2026
Aug. 5, 2026

Telix to Host R&D Day in New York City on September 22, 2026

Indeterminate GlobeNewswire
Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001
Aug. 5, 2026

Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001

Indeterminate GlobeNewswire
PLNT Legal News: Planet Fitness Hit with Securities Fraud Class Action over Alleged Misrepresentations about its Membership Growth – Contact BFA Law
Aug. 5, 2026

PLNT Legal News: Planet Fitness Hit with Securities Fraud Class Action over Alleged Misrepresentations about its Membership Growth – Contact BFA Law

Indeterminate GlobeNewswire
Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program
Aug. 5, 2026

Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program

Indeterminate GlobeNewswire
CorVel Announces Revenues and Earnings
Aug. 5, 2026

CorVel Announces Revenues and Earnings

Indeterminate GlobeNewswire
Marvel Biosciences Reports Positive Preclinical Data Demonstrating MB-204 Reverses Behavioural and Cognitive Deficits in a Mouse Model of Fragile X
Aug. 5, 2026

Marvel Biosciences Reports Positive Preclinical Data Demonstrating MB-204 Reverses Behavioural and Cognitive Deficits in a Mouse Model of Fragile X

Indeterminate GlobeNewswire
Bluesight Launches Revenue Optimization Capabilities, Expanding Margin Insights for Hospital Pharmacies
Aug. 5, 2026

Bluesight Launches Revenue Optimization Capabilities, Expanding Margin Insights for Hospital Pharmacies

Indeterminate GlobeNewswire
Mironid raises $46 million in Series B financing to advance clinical development of its treatment for rare kidney disease
Aug. 5, 2026

Mironid raises $46 million in Series B financing to advance clinical development of its treatment for rare kidney disease

Indeterminate GlobeNewswire
Basilea erhält zusätzliche USD 5.4 Mio. von BARDA zur Entwicklung des neuartigen Antibiotikums Ceftibuten-Ledaborbactam
Aug. 5, 2026

Basilea erhält zusätzliche USD 5.4 Mio. von BARDA zur Entwicklung des neuartigen Antibiotikums Ceftibuten-Ledaborbactam

Indeterminate GlobeNewswire
Basilea receives additional USD 5.4 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
Aug. 5, 2026

Basilea receives additional USD 5.4 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam

Indeterminate GlobeNewswire
Liupanshui Turns Cool Summers into a New Way of Life
Aug. 5, 2026

Liupanshui Turns Cool Summers into a New Way of Life

Indeterminate GlobeNewswire
Grace Therapeutics Announces $10 Million Private Placement
Aug. 5, 2026

Grace Therapeutics Announces $10 Million Private Placement

Indeterminate GlobeNewswire
JOSTENS® RENAISSANCE® GLOBAL CONFERENCE 2026 INSPIRES THOUSANDS TO LOVE MONDAYS™
Aug. 5, 2026

JOSTENS® RENAISSANCE® GLOBAL CONFERENCE 2026 INSPIRES THOUSANDS TO LOVE MONDAYS™

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

World Wellness Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.